| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | PHC3 MBTD1 NANOGP8 MTA3 EP400 NFATC2 NFATC3 NFE2L1 SUPT6H ASXL3 NANOG PKNOX1 ANKRD17 ACTN4 CHD7 RUNX2 ARID1A LCOR MEIS1 CUX1 PHC1 | 2.37e-14 | 739 | 68 | 21 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | NANOGP8 NFATC2 NFATC3 ARID2 NANOG ARNT2 CRTC1 ACTN4 RUNX2 ARID1A PPID LCOR | 7.93e-06 | 753 | 68 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | histone binding | 3.26e-05 | 265 | 68 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 6.83e-05 | 4 | 68 | 2 | GO:0001010 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.14e-04 | 560 | 68 | 9 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.23e-04 | 566 | 68 | 9 | GO:0001216 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NANOGP8 MRTFB MTA3 NANOG HGS ACTN4 EWSR1 MAML2 ARID1A WNK1 LCOR CAPRIN1 CUX1 | 1.27e-04 | 1160 | 68 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NANOGP8 MRTFB MTA3 NFATC2 NANOG HGS ACTN4 EWSR1 MAML2 ARID1A WNK1 LCOR CAPRIN1 CUX1 | 1.59e-04 | 1356 | 68 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NANOGP8 NFATC2 NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 CHD7 EBF1 RUNX2 MEIS1 CUX1 | 2.53e-04 | 1244 | 68 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.70e-04 | 37 | 68 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NANOGP8 NFATC2 NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 CHD7 EBF1 RUNX2 MEIS1 CUX1 | 3.11e-04 | 1271 | 68 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NANOGP8 NFATC2 NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 ACTN4 CHD7 EBF1 RUNX2 MEIS1 CUX1 | 3.40e-04 | 1459 | 68 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NANOGP8 NFATC2 NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 EBF1 RUNX2 MEIS1 CUX1 | 2.69e-03 | 1412 | 68 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.96e-03 | 562 | 68 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.59e-03 | 582 | 68 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.72e-03 | 303 | 68 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.80e-03 | 187 | 68 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.20e-03 | 599 | 68 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 4.67e-03 | 30 | 68 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.68e-03 | 320 | 68 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.99e-03 | 31 | 68 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.06e-03 | 326 | 68 | 5 | GO:0001217 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NANOGP8 MRTFB NFATC2 NFATC3 NFE2L1 SUPT6H ASXL3 ARID2 NANOG ARNT2 PKNOX1 CRTC1 ACTN4 CHD7 EBF1 MAML2 EYA1 RUNX2 MEIS1 | 5.25e-08 | 1390 | 67 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 9.27e-06 | 150 | 67 | 6 | GO:0050773 | |
| GeneOntologyBiologicalProcess | vasculature development | MRTFB FN1 NFATC2 NFATC3 ARID2 HGS PKNOX1 ANKRD17 CHD7 EYA1 ARID1A WNK1 MEIS1 | 1.20e-05 | 969 | 67 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 2.13e-05 | 103 | 67 | 5 | GO:0048814 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 2.58e-05 | 18 | 67 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | blood vessel development | MRTFB FN1 NFATC3 ARID2 HGS PKNOX1 ANKRD17 CHD7 EYA1 ARID1A WNK1 MEIS1 | 3.95e-05 | 929 | 67 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | embryo development | MBTD1 NANOGP8 MRTFB FN1 SUPT6H ARID2 NANOG ARNT2 POU3F4 CHD7 EYA1 RUNX2 ARID1A WNK1 MEIS1 | 4.52e-05 | 1437 | 67 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of cell division | 4.84e-05 | 201 | 67 | 6 | GO:0051302 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 5.19e-05 | 124 | 67 | 5 | GO:0001704 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 5.54e-05 | 23 | 67 | 3 | GO:0001710 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 6.21e-05 | 4 | 67 | 2 | GO:0042664 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell differentiation | 6.31e-05 | 24 | 67 | 3 | GO:0051151 | |
| GeneOntologyBiologicalProcess | gastrulation | 6.50e-05 | 212 | 67 | 6 | GO:0007369 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 6.68e-05 | 67 | 67 | 4 | GO:0050775 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 7.50e-05 | 69 | 67 | 4 | GO:0010770 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.02e-04 | 143 | 67 | 5 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.03e-04 | 5 | 67 | 2 | GO:0042663 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 1.13e-04 | 29 | 67 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | PHC3 MBTD1 NANOGP8 MTA3 NFATC2 NFATC3 NFE2L1 NANOG RUNX2 ARID1A PPID LCOR CUX1 PHC1 | 1.33e-04 | 1399 | 67 | 14 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | PHC3 MBTD1 NANOGP8 MTA3 NFATC2 NFATC3 NFE2L1 NANOG RUNX2 ARID1A PPID LCOR CUX1 PHC1 | 1.48e-04 | 1413 | 67 | 14 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.55e-04 | 6 | 67 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.59e-04 | 614 | 67 | 9 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | MBTD1 NANOGP8 SH3GLB1 MTA3 EP400 NFE2L1 ARID2 NANOG ANKRD17 EVI2B ARID1A MAP10 WNK1 | 1.73e-04 | 1256 | 67 | 13 | GO:0051726 |
| GeneOntologyBiologicalProcess | endoderm development | 1.93e-04 | 88 | 67 | 4 | GO:0007492 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 1.99e-04 | 35 | 67 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.29e-04 | 92 | 67 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in formation of primary germ layer | 2.35e-04 | 37 | 67 | 3 | GO:0060795 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 2.55e-04 | 38 | 67 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 2.59e-04 | 95 | 67 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 2.87e-04 | 8 | 67 | 2 | GO:0009996 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.88e-04 | 817 | 67 | 10 | GO:0048514 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 3.04e-04 | 99 | 67 | 4 | GO:0051145 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 3.15e-04 | 531 | 67 | 8 | GO:0042692 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MBTD1 MTA3 EP400 CENPC SUPT6H ARID2 CHD7 EYA1 ARID1A LCOR PHC1 | 3.47e-04 | 999 | 67 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | semicircular canal morphogenesis | 3.69e-04 | 9 | 67 | 2 | GO:0048752 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 3.74e-04 | 412 | 67 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NANOGP8 MTA3 CENPC NFE2L1 ARID2 NANOG ANKRD17 EYA1 ARID1A MAP10 WNK1 | 3.93e-04 | 1014 | 67 | 11 | GO:0000278 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 3.94e-04 | 44 | 67 | 3 | GO:1905168 | |
| GeneOntologyBiologicalProcess | muscle structure development | MRTFB NFATC2 NFATC3 SUPT6H ARID2 ANKRD17 ACTN4 CHD7 ARID1A MEIS1 | 4.25e-04 | 858 | 67 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 4.60e-04 | 10 | 67 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 4.62e-04 | 198 | 67 | 5 | GO:0048813 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.77e-04 | 713 | 67 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | tube development | MRTFB FN1 NFATC3 ARID2 HGS PKNOX1 RCBTB2 CHD7 EYA1 ARID1A WNK1 MEIS1 CUX1 | 5.03e-04 | 1402 | 67 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | endoderm formation | 5.42e-04 | 49 | 67 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | stem cell division | 5.42e-04 | 49 | 67 | 3 | GO:0017145 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 5.61e-04 | 11 | 67 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 5.61e-04 | 11 | 67 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 5.61e-04 | 11 | 67 | 2 | GO:0060872 | |
| GeneOntologyBiologicalProcess | chromatin organization | 5.96e-04 | 896 | 67 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 6.29e-04 | 741 | 67 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | circulatory system development | MRTFB FN1 NFATC2 NFATC3 ARID2 HGS PKNOX1 ANKRD17 CHD7 EYA1 ARID1A WNK1 MEIS1 | 6.56e-04 | 1442 | 67 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte progenitor proliferation | 6.72e-04 | 12 | 67 | 2 | GO:0070445 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 6.83e-04 | 53 | 67 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | cell fate specification | 6.91e-04 | 123 | 67 | 4 | GO:0001708 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 7.22e-04 | 54 | 67 | 3 | GO:0051150 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 7.29e-04 | 219 | 67 | 5 | GO:0071248 | |
| GeneOntologyBiologicalProcess | heart development | 7.33e-04 | 757 | 67 | 9 | GO:0007507 | |
| GeneOntologyBiologicalProcess | regulation of cell development | SH3GLB1 FN1 PTPRZ1 ARID2 EVI2B AFDN CHD7 ARID1A CAPRIN1 MEIS1 CUX1 | 7.48e-04 | 1095 | 67 | 11 | GO:0060284 |
| GeneOntologyBiologicalProcess | dendrite development | 7.62e-04 | 335 | 67 | 6 | GO:0016358 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell differentiation | 7.62e-04 | 55 | 67 | 3 | GO:0035886 | |
| GeneOntologyBiologicalProcess | regulation of ribonucleoprotein complex localization | 7.92e-04 | 13 | 67 | 2 | GO:2000197 | |
| GeneOntologyBiologicalProcess | oligodendrocyte progenitor proliferation | 7.92e-04 | 13 | 67 | 2 | GO:0070444 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle cell differentiation | 7.92e-04 | 13 | 67 | 2 | GO:1905064 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 7.98e-04 | 338 | 67 | 6 | GO:0045165 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 9.22e-04 | 14 | 67 | 2 | GO:0071166 | |
| GeneOntologyBiologicalProcess | artery development | 9.25e-04 | 133 | 67 | 4 | GO:0060840 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | MRTFB FN1 NFATC3 ARID2 HGS PKNOX1 CHD7 EYA1 ARID1A WNK1 MEIS1 | 9.34e-04 | 1125 | 67 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 9.42e-04 | 349 | 67 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 9.81e-04 | 234 | 67 | 5 | GO:0006282 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.01e-03 | 354 | 67 | 6 | GO:0050769 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 1.06e-03 | 15 | 67 | 2 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 1.06e-03 | 15 | 67 | 2 | GO:0043696 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.09e-03 | 494 | 67 | 7 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.31e-03 | 146 | 67 | 4 | GO:2000779 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 1.37e-03 | 17 | 67 | 2 | GO:0010454 | |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 1.37e-03 | 17 | 67 | 2 | GO:0046831 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.39e-03 | 515 | 67 | 7 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.44e-03 | 150 | 67 | 4 | GO:0000018 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | NANOGP8 FN1 MTA3 CD244 NFATC2 PTPRZ1 NANOG ARNT2 EYA1 RUNX2 MEIS1 | 1.47e-03 | 1190 | 67 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.50e-03 | 382 | 67 | 6 | GO:0030217 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.54e-03 | 18 | 67 | 2 | GO:0001711 | |
| GeneOntologyBiologicalProcess | central nervous system development | SCYL2 MRTFB NFE2L1 PTPRZ1 ARNT2 SEC16A AFDN POU3F4 CHD7 ARID1A MEIS1 | 1.54e-03 | 1197 | 67 | 11 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 1.58e-03 | 845 | 67 | 9 | GO:0010564 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle | 1.63e-03 | 155 | 67 | 4 | GO:0045931 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 1.70e-03 | 854 | 67 | 9 | GO:1903047 | |
| GeneOntologyBiologicalProcess | mesoderm development | 1.71e-03 | 157 | 67 | 4 | GO:0007498 | |
| GeneOntologyBiologicalProcess | brain development | 1.77e-03 | 859 | 67 | 9 | GO:0007420 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 1.90e-03 | 20 | 67 | 2 | GO:0032239 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NANOGP8 MTA3 NFATC2 NFATC3 NFE2L1 NANOG ARID1A PPID LCOR CUX1 | 2.02e-03 | 1053 | 67 | 10 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 2.06e-03 | 407 | 67 | 6 | GO:0045787 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 2.18e-03 | 558 | 67 | 7 | GO:0060537 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 2.25e-03 | 561 | 67 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 2.25e-03 | 80 | 67 | 3 | GO:0045911 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 2.30e-03 | 22 | 67 | 2 | GO:0006337 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 2.30e-03 | 22 | 67 | 2 | GO:1900006 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.32e-03 | 564 | 67 | 7 | GO:0051052 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.35e-03 | 418 | 67 | 6 | GO:0051962 | |
| GeneOntologyBiologicalProcess | mesoderm formation | 2.42e-03 | 82 | 67 | 3 | GO:0001707 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 2.50e-03 | 83 | 67 | 3 | GO:0051148 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 2.50e-03 | 83 | 67 | 3 | GO:0010569 | |
| GeneOntologyCellularComponent | chromatin | MBTD1 NANOGP8 MTA3 EP400 CENPC NFATC2 NFATC3 NFE2L1 ARID2 NANOG ARNT2 PKNOX1 ANKRD17 POU3F4 CHD7 EBF1 RUNX2 ARID1A MEIS1 CUX1 PHC1 | 4.59e-09 | 1480 | 68 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.72e-04 | 96 | 68 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | PcG protein complex | 6.49e-04 | 52 | 68 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | transcription regulator complex | 6.84e-04 | 596 | 68 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | ATPase complex | 8.31e-04 | 129 | 68 | 4 | GO:1904949 | |
| MousePheno | abnormal cardiovascular development | MRTFB FN1 ARID2 HGS PKNOX1 ANKRD17 ACTN4 CHD7 EYA1 RUNX2 ARID1A WNK1 DCBLD2 MEIS1 PHC1 | 9.90e-07 | 802 | 60 | 15 | MP:0002925 |
| MousePheno | abnormal vascular development | MRTFB FN1 ARID2 PKNOX1 ANKRD17 ACTN4 CHD7 RUNX2 ARID1A WNK1 DCBLD2 MEIS1 | 2.61e-06 | 542 | 60 | 12 | MP:0000259 |
| MousePheno | abnormal angiogenesis | 3.64e-06 | 372 | 60 | 10 | MP:0000260 | |
| MousePheno | abnormal hematopoietic precursor cell morphology | 3.89e-05 | 299 | 60 | 8 | MP:0013707 | |
| MousePheno | abnormal superior semicircular canal morphology | 4.05e-05 | 16 | 60 | 3 | MP:0003069 | |
| MousePheno | abnormal blood circulation | MRTFB FN1 ASXL3 ARID2 PKNOX1 ANKRD17 ACTN4 CHD7 ARID1A WNK1 TNS1 DCBLD2 MEIS1 | 4.78e-05 | 845 | 60 | 13 | MP:0002128 |
| MousePheno | abnormal stapes footplate morphology | 5.42e-05 | 3 | 60 | 2 | MP:0004290 | |
| MousePheno | conductive hearing impairment | 6.94e-05 | 19 | 60 | 3 | MP:0006326 | |
| MousePheno | abnormal lateral semicircular canal morphology | 9.46e-05 | 21 | 60 | 3 | MP:0000037 | |
| MousePheno | decreased superior semicircular canal size | 1.08e-04 | 4 | 60 | 2 | MP:0003166 | |
| MousePheno | ventricular septal defect | 1.21e-04 | 261 | 60 | 7 | MP:0010402 | |
| MousePheno | abnormal neurocranium morphology | 1.46e-04 | 269 | 60 | 7 | MP:0000074 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | FN1 EP400 NFE2L1 ARID2 HGS ANKRD17 AFDN CHD7 ARID1A WNK1 MEIS1 | 1.66e-04 | 700 | 60 | 11 | MP:0011098 |
| MousePheno | abnormal oval window morphology | 1.80e-04 | 5 | 60 | 2 | MP:0004479 | |
| MousePheno | abnormal stapes crus morpholgy | 1.80e-04 | 5 | 60 | 2 | MP:0030407 | |
| MousePheno | abnormal basicranium morphology | 1.80e-04 | 123 | 60 | 5 | MP:0010029 | |
| MousePheno | abnormal muscle morphology | MRTFB FN1 NFATC3 ASXL3 ARID2 HGS ANKRD17 ACTN4 EWSR1 CHD7 EYA1 ARID1A WNK1 PHC1 | 1.91e-04 | 1106 | 60 | 14 | MP:0002108 |
| MousePheno | abnormal embryonic tissue morphology | NANOGP8 MRTFB FN1 EP400 NFE2L1 NANOG HGS PKNOX1 ANKRD17 AFDN ACTN4 CHD7 EYA1 ARID1A | 2.09e-04 | 1116 | 60 | 14 | MP:0002085 |
| MousePheno | abnormal cardiac muscle tissue morphology | 2.20e-04 | 489 | 60 | 9 | MP:0010630 | |
| MousePheno | abnormal artery development | 2.60e-04 | 133 | 60 | 5 | MP:0003410 | |
| MousePheno | decreased posterior semicircular canal size | 2.69e-04 | 6 | 60 | 2 | MP:0003164 | |
| MousePheno | abnormal stapes morphology | 3.10e-04 | 31 | 60 | 3 | MP:0005107 | |
| MousePheno | abnormal myocardium layer morphology | 3.67e-04 | 414 | 60 | 8 | MP:0005329 | |
| MousePheno | abnormal cranial foramen morphology | 3.74e-04 | 33 | 60 | 3 | MP:0030310 | |
| MousePheno | small occipital bone | 3.75e-04 | 7 | 60 | 2 | MP:0004441 | |
| MousePheno | decreased lateral semicircular canal size | 3.75e-04 | 7 | 60 | 2 | MP:0003162 | |
| MousePheno | abnormal heart layer morphology | 4.17e-04 | 422 | 60 | 8 | MP:0010545 | |
| MousePheno | hemorrhage | 4.78e-04 | 664 | 60 | 10 | MP:0001914 | |
| MousePheno | thin myocardium | 4.79e-04 | 85 | 60 | 4 | MP:0002652 | |
| MousePheno | periorbital edema | 4.99e-04 | 8 | 60 | 2 | MP:0001788 | |
| MousePheno | abnormal artery morphology | 5.50e-04 | 440 | 60 | 8 | MP:0002191 | |
| MousePheno | abnormal definitive hematopoiesis | LRFN2 EP400 NFE2L1 PKNOX1 EWSR1 EBF1 RUNX2 CTSE MEIS1 CUX1 PHC1 | 5.69e-04 | 808 | 60 | 11 | MP:0002123 |
| MousePheno | abnormal thymus size | 6.25e-04 | 564 | 60 | 9 | MP:0002364 | |
| MousePheno | abnormal interventricular septum morphology | 6.26e-04 | 342 | 60 | 7 | MP:0000281 | |
| MousePheno | absent primitive endoderm | 6.40e-04 | 9 | 60 | 2 | MP:0011185 | |
| MousePheno | absent posterior semicircular canal | 6.40e-04 | 9 | 60 | 2 | MP:0003163 | |
| MousePheno | abnormal middle ear morphology | 6.46e-04 | 92 | 60 | 4 | MP:0000049 | |
| MousePheno | abnormal fluid regulation | MRTFB NFATC3 LORICRIN ARID2 PKNOX1 ANKRD17 ACTN4 EWSR1 CHD7 ARID1A WNK1 | 6.85e-04 | 826 | 60 | 11 | MP:0001784 |
| MousePheno | interrupted aortic arch | 7.14e-04 | 41 | 60 | 3 | MP:0004157 | |
| MousePheno | abnormal occipital bone morphology | 7.30e-04 | 95 | 60 | 4 | MP:0005269 | |
| MousePheno | abnormal optic cup morphology | 7.66e-04 | 42 | 60 | 3 | MP:0004269 | |
| MousePheno | abnormal pluripotent precursor cell morphology | 7.66e-04 | 42 | 60 | 3 | MP:0002399 | |
| MousePheno | cervical vertebral fusion | 7.66e-04 | 42 | 60 | 3 | MP:0004620 | |
| MousePheno | abnormal hemopoiesis | LRFN2 EP400 NFE2L1 PKNOX1 EWSR1 EBF1 RUNX2 CTSE MEIS1 CUX1 PHC1 | 7.79e-04 | 839 | 60 | 11 | MP:0013693 |
| MousePheno | abnormal ischium morphology | 7.97e-04 | 10 | 60 | 2 | MP:0004507 | |
| MousePheno | abnormal periorbital region morphology | 7.97e-04 | 10 | 60 | 2 | MP:0030038 | |
| MousePheno | interrupted aorta | 8.21e-04 | 43 | 60 | 3 | MP:0010544 | |
| MousePheno | perinatal lethality | SCYL2 MBTD1 MRTFB NFE2L1 ARNT2 PKNOX1 ACTN4 EYA1 RUNX2 ARID1A CAPRIN1 CUX1 PHC1 | 8.41e-04 | 1130 | 60 | 13 | MP:0002081 |
| MousePheno | abnormal blood cell morphology/development | LRFN2 FN1 EP400 NFE2L1 PKNOX1 EWSR1 EBF1 RUNX2 CTSE MEIS1 CUX1 PHC1 | 8.44e-04 | 986 | 60 | 12 | MP:0002429 |
| MousePheno | abnormal thymus morphology | 8.69e-04 | 717 | 60 | 10 | MP:0000703 | |
| MousePheno | trunk curl | 9.38e-04 | 45 | 60 | 3 | MP:0001512 | |
| MousePheno | abnormal common crus morphology | 9.72e-04 | 11 | 60 | 2 | MP:0004922 | |
| MousePheno | increased nucleated erythrocyte cell number | 1.07e-03 | 47 | 60 | 3 | MP:0009395 | |
| MousePheno | embryonic lethality during organogenesis | FN1 EP400 NFE2L1 ARID2 HGS ANKRD17 AFDN CHD7 ARID1A WNK1 MEIS1 | 1.11e-03 | 876 | 60 | 11 | MP:0006207 |
| MousePheno | abnormal bony labyrinth | 1.16e-03 | 12 | 60 | 2 | MP:0004289 | |
| MousePheno | abnormal nucleated erythrocyte cell number | 1.20e-03 | 49 | 60 | 3 | MP:0012397 | |
| MousePheno | pale yolk sac | 1.26e-03 | 110 | 60 | 4 | MP:0001722 | |
| MousePheno | abnormal heart septum morphology | 1.31e-03 | 388 | 60 | 7 | MP:0006113 | |
| MousePheno | head bobbing | 1.35e-03 | 51 | 60 | 3 | MP:0001410 | |
| MousePheno | abnormal common carotid artery morphology | 1.37e-03 | 13 | 60 | 2 | MP:0012729 | |
| MousePheno | absent lateral semicircular canal | 1.37e-03 | 13 | 60 | 2 | MP:0003161 | |
| MousePheno | small thymus | 1.38e-03 | 286 | 60 | 6 | MP:0000706 | |
| MousePheno | abnormal extraembryonic tissue morphology | NANOGP8 MRTFB FN1 NANOG HGS PKNOX1 ANKRD17 AFDN EBF1 ARID1A WNK1 | 1.49e-03 | 908 | 60 | 11 | MP:0002086 |
| Domain | Znf_FCS | 4.19e-07 | 5 | 66 | 3 | IPR012313 | |
| Domain | ZF_FCS | 8.37e-07 | 6 | 66 | 3 | PS51024 | |
| Domain | Homeodomain-like | 2.42e-06 | 332 | 66 | 9 | IPR009057 | |
| Domain | - | 1.04e-04 | 663 | 66 | 10 | 2.60.40.10 | |
| Domain | IPT | 1.16e-04 | 27 | 66 | 3 | SM00429 | |
| Domain | NFAT | 1.22e-04 | 5 | 66 | 2 | IPR008366 | |
| Domain | PKNOX/Meis_N | 1.22e-04 | 5 | 66 | 2 | IPR032453 | |
| Domain | Meis_PKNOX_N | 1.22e-04 | 5 | 66 | 2 | PF16493 | |
| Domain | Ig-like_fold | 1.74e-04 | 706 | 66 | 10 | IPR013783 | |
| Domain | Homeobox | 1.76e-04 | 234 | 66 | 6 | PF00046 | |
| Domain | TIG | 1.77e-04 | 31 | 66 | 3 | PF01833 | |
| Domain | HOMEOBOX_1 | 1.84e-04 | 236 | 66 | 6 | PS00027 | |
| Domain | HOX | 1.89e-04 | 237 | 66 | 6 | SM00389 | |
| Domain | IPT | 1.94e-04 | 32 | 66 | 3 | IPR002909 | |
| Domain | HOMEOBOX_2 | 1.97e-04 | 239 | 66 | 6 | PS50071 | |
| Domain | Homeobox_dom | 1.97e-04 | 239 | 66 | 6 | IPR001356 | |
| Domain | RHD_dimer | 5.43e-04 | 10 | 66 | 2 | IPR032397 | |
| Domain | RHD_dimer | 5.43e-04 | 10 | 66 | 2 | PF16179 | |
| Domain | NFkB/Dor | 5.43e-04 | 10 | 66 | 2 | IPR000451 | |
| Domain | REL_1 | 5.43e-04 | 10 | 66 | 2 | PS01204 | |
| Domain | RHD_DNA_bind_dom | 5.43e-04 | 10 | 66 | 2 | IPR011539 | |
| Domain | RHD_DNA_bind | 5.43e-04 | 10 | 66 | 2 | PF00554 | |
| Domain | REL_2 | 5.43e-04 | 10 | 66 | 2 | PS50254 | |
| Domain | - | 5.43e-04 | 10 | 66 | 2 | 2.60.40.340 | |
| Domain | SANT | 7.34e-04 | 50 | 66 | 3 | SM00717 | |
| Domain | SANT/Myb | 8.23e-04 | 52 | 66 | 3 | IPR001005 | |
| Domain | p53-like_TF_DNA-bd | 8.70e-04 | 53 | 66 | 3 | IPR008967 | |
| Domain | - | 1.25e-03 | 15 | 66 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.25e-03 | 15 | 66 | 2 | SM00501 | |
| Domain | ARID_dom | 1.25e-03 | 15 | 66 | 2 | IPR001606 | |
| Domain | ARID | 1.25e-03 | 15 | 66 | 2 | PS51011 | |
| Domain | ARID | 1.25e-03 | 15 | 66 | 2 | PF01388 | |
| Domain | Homeobox_KN | 1.62e-03 | 17 | 66 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 1.62e-03 | 17 | 66 | 2 | IPR008422 | |
| Domain | - | 3.24e-03 | 283 | 66 | 5 | 1.10.10.60 | |
| Domain | - | 4.08e-03 | 27 | 66 | 2 | 1.10.260.40 | |
| Domain | Ig_I-set | 4.58e-03 | 190 | 66 | 4 | IPR013098 | |
| Domain | I-set | 4.58e-03 | 190 | 66 | 4 | PF07679 | |
| Domain | Lambda_DNA-bd_dom | 4.70e-03 | 29 | 66 | 2 | IPR010982 | |
| Domain | SH2 | 5.49e-03 | 101 | 66 | 3 | PF00017 | |
| Domain | SNF2_N | 5.70e-03 | 32 | 66 | 2 | IPR000330 | |
| Domain | SNF2_N | 5.70e-03 | 32 | 66 | 2 | PF00176 | |
| Domain | Ig_E-set | 5.95e-03 | 104 | 66 | 3 | IPR014756 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.79e-03 | 35 | 66 | 2 | IPR002464 | |
| Domain | SH2 | 6.95e-03 | 110 | 66 | 3 | SM00252 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 7.82e-06 | 37 | 49 | 4 | M27797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 9.70e-05 | 26 | 49 | 3 | M47923 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.62e-04 | 237 | 49 | 6 | M27786 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.19e-04 | 34 | 49 | 3 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 3.56e-04 | 40 | 49 | 3 | M47917 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 4.20e-04 | 9 | 49 | 2 | M27106 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 6.38e-04 | 11 | 49 | 2 | MM14810 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 6.38e-04 | 11 | 49 | 2 | M27466 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 6.73e-04 | 431 | 49 | 7 | M39729 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | MBTD1 NANOGP8 MTA3 EP400 SUPT6H NANOG SEC16A CHD7 ARID1A PHC1 | 3.42e-13 | 146 | 69 | 10 | 23892456 |
| Pubmed | MTA3 NFATC2 NFE2L1 ARNT2 PKNOX1 AFDN POU3F4 EWSR1 EBF1 ARID1A LCOR MEIS1 CUX1 PHC1 | 1.04e-10 | 709 | 69 | 14 | 22988430 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | PHC3 MBTD1 EP400 ARID2 SEC16A CHD7 ARID1A PPID LCOR CUX1 GOT1 | 3.87e-10 | 398 | 69 | 11 | 35016035 |
| Pubmed | NANOGP8 MTA3 NFE2L1 ARID2 NANOG ARNT2 PKNOX1 EBF1 RUNX2 ARID1A LCOR MEIS1 CUX1 PHC1 | 5.66e-10 | 808 | 69 | 14 | 20412781 | |
| Pubmed | 9.54e-10 | 157 | 69 | 8 | 30186101 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MBTD1 MRTFB EP400 NFATC3 SUPT6H ARID2 SEC16A HELZ CHD7 ARID1A CFAP44 WNK1 | 1.79e-09 | 588 | 69 | 12 | 38580884 |
| Pubmed | FN1 SUPT6H SEC16A ANKRD17 HELZ AFDN ACTN4 EWSR1 CHD7 ARID1A CAPRIN1 | 6.39e-08 | 653 | 69 | 11 | 22586326 | |
| Pubmed | PHC1 maintains pluripotency by organizing genome-wide chromatin interactions of the Nanog locus. | 7.45e-08 | 5 | 69 | 3 | 33990559 | |
| Pubmed | 9.22e-08 | 282 | 69 | 8 | 23667531 | ||
| Pubmed | PHC3 MBTD1 MTA3 EP400 NFATC3 ARID2 HGS SEC16A ANKRD17 HELZ EWSR1 CHD7 ARID1A CAPRIN1 CUX1 | 1.05e-07 | 1429 | 69 | 15 | 35140242 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.20e-07 | 332 | 69 | 8 | 30595499 | |
| Pubmed | 3.99e-07 | 472 | 69 | 9 | 38943005 | ||
| Pubmed | 4.16e-07 | 8 | 69 | 3 | 28373172 | ||
| Pubmed | 4.69e-07 | 77 | 69 | 5 | 19505873 | ||
| Pubmed | 4.89e-07 | 32 | 69 | 4 | 19542561 | ||
| Pubmed | 5.09e-07 | 486 | 69 | 9 | 20936779 | ||
| Pubmed | 8.92e-07 | 37 | 69 | 4 | 24335282 | ||
| Pubmed | PHC3 MRTFB MTA3 EP400 NFATC2 SUPT6H ARID2 AAK1 ANKRD17 HELZ CRTC1 AFDN CHD7 SPATS2 | 1.18e-06 | 1497 | 69 | 14 | 31527615 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 EWSR1 EBF1 RUNX2 LCOR MEIS1 | 1.18e-06 | 877 | 69 | 11 | 20211142 |
| Pubmed | PHC3 MBTD1 FN1 PAPOLA NFE2L1 SEC16A ANKRD17 CRTC1 ACTN4 CHD7 WNK1 TNS1 | 1.36e-06 | 1084 | 69 | 12 | 11544199 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.58e-06 | 411 | 69 | 8 | 35182466 | |
| Pubmed | 1.62e-06 | 12 | 69 | 3 | 18448678 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | NFATC2 NFATC3 NFE2L1 NANOG ARNT2 PKNOX1 POU3F4 EBF1 RUNX2 LCOR MEIS1 | 1.66e-06 | 908 | 69 | 11 | 19274049 |
| Pubmed | 1.79e-06 | 418 | 69 | 8 | 34709266 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SCYL2 PHC3 MRTFB EP400 PAPOLA ARID2 SEC16A AAK1 ANKRD17 HELZ WNK1 | 2.18e-06 | 934 | 69 | 11 | 33916271 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.21e-06 | 430 | 69 | 8 | 35044719 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PHC3 EP400 CENPC ARID2 SEC16A AFDN EWSR1 CHD7 ARID1A LCOR CUX1 | 2.67e-06 | 954 | 69 | 11 | 36373674 |
| Pubmed | NFATC3 SEC16A AAK1 ANKRD17 AFDN EWSR1 CHD7 SPATS2 TNS1 CAPRIN1 CUX1 | 2.92e-06 | 963 | 69 | 11 | 28671696 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31392992 | ||
| Pubmed | Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. | 3.88e-06 | 2 | 69 | 2 | 19269006 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 28343305 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 29626598 | ||
| Pubmed | Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma. | 3.88e-06 | 2 | 69 | 2 | 38254207 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 14720503 | ||
| Pubmed | Dynamic response diversity of NFAT isoforms in individual living cells. | 3.88e-06 | 2 | 69 | 2 | 23219532 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 34081036 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30895378 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 30994538 | ||
| Pubmed | A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. | 3.88e-06 | 2 | 69 | 2 | 16051745 | |
| Pubmed | Functional evidence that the self-renewal gene NANOG regulates human tumor development. | 3.88e-06 | 2 | 69 | 2 | 19415763 | |
| Pubmed | Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens. | 3.88e-06 | 2 | 69 | 2 | 36675234 | |
| Pubmed | Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. | 3.88e-06 | 2 | 69 | 2 | 17334997 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26796488 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15729701 | ||
| Pubmed | Regulation of NFATc2 gene expression by the transcription factor Runx2. | 3.88e-06 | 2 | 69 | 2 | 17103021 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27863227 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 20625861 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24598770 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26503699 | ||
| Pubmed | Differential expression of nanog1 and nanogp8 in colon cancer cells. | 3.88e-06 | 2 | 69 | 2 | 22079639 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27769871 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 21074686 | ||
| Pubmed | The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. | 3.88e-06 | 2 | 69 | 2 | 33830080 | |
| Pubmed | A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. | 3.88e-06 | 2 | 69 | 2 | 20588178 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 24771140 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 34657306 | ||
| Pubmed | CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. | 3.88e-06 | 2 | 69 | 2 | 30380176 | |
| Pubmed | C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein. | 3.88e-06 | 2 | 69 | 2 | 21900201 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 17437281 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 15657288 | ||
| Pubmed | Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. | 3.88e-06 | 2 | 69 | 2 | 9846484 | |
| Pubmed | Band-pass processing in a GPCR signaling pathway selects for NFAT transcription factor activation. | 3.88e-06 | 2 | 69 | 2 | 26374065 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 9498773 | ||
| Pubmed | MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. | 3.88e-06 | 2 | 69 | 2 | 16818685 | |
| Pubmed | Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. | 3.88e-06 | 2 | 69 | 2 | 21136380 | |
| Pubmed | Distinct spatial Ca2+ signatures selectively activate different NFAT transcription factor isoforms. | 3.88e-06 | 2 | 69 | 2 | 25818645 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 18206539 | ||
| Pubmed | PAPOLA HGS SEC16A ANKRD17 ACTN4 EWSR1 SPATS2 RUNX2 ARID1A PPID CAPRIN1 CUX1 | 5.71e-06 | 1247 | 69 | 12 | 27684187 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.34e-06 | 351 | 69 | 7 | 38297188 | |
| Pubmed | 6.40e-06 | 497 | 69 | 8 | 23414517 | ||
| Pubmed | 1.01e-05 | 529 | 69 | 8 | 14621295 | ||
| Pubmed | MTA3 EP400 ARID2 ACTN4 EWSR1 CHD7 RUNX2 ARID1A LCOR CAPRIN1 CUX1 | 1.05e-05 | 1103 | 69 | 11 | 34189442 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.11e-05 | 69 | 69 | 4 | 28481362 | |
| Pubmed | 1.12e-05 | 22 | 69 | 3 | 24301466 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19447925 | ||
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.16e-05 | 3 | 69 | 2 | 30814124 | |
| Pubmed | Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. | 1.16e-05 | 3 | 69 | 2 | 33473104 | |
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.16e-05 | 3 | 69 | 2 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.16e-05 | 3 | 69 | 2 | 17554338 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.16e-05 | 3 | 69 | 2 | 26660234 | |
| Pubmed | FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts. | 1.16e-05 | 3 | 69 | 2 | 32991339 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.16e-05 | 3 | 69 | 2 | 18177668 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 7650004 | ||
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.16e-05 | 3 | 69 | 2 | 16259959 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12609610 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 34234374 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24227785 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 29353885 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.16e-05 | 3 | 69 | 2 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.16e-05 | 3 | 69 | 2 | 23770853 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 15502159 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.16e-05 | 3 | 69 | 2 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.16e-05 | 3 | 69 | 2 | 23054952 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.16e-05 | 3 | 69 | 2 | 24527385 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18086680 | ||
| Pubmed | The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis. | 1.16e-05 | 3 | 69 | 2 | 24809472 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 17204467 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 27402217 | ||
| Interaction | FBXO42 interactions | MRTFB EP400 ARID2 SEC16A HELZ CHD7 ARID1A CFAP44 WNK1 CAPRIN1 | 1.16e-08 | 259 | 66 | 10 | int:FBXO42 |
| Interaction | SOX9 interactions | 2.97e-08 | 97 | 66 | 7 | int:SOX9 | |
| Interaction | CREBBP interactions | PAPOLA NFATC2 SUPT6H ARNT2 HELZ CRTC1 EWSR1 EBF1 MAML2 RUNX2 ARID1A MEIS1 CUX1 | 5.98e-08 | 599 | 66 | 13 | int:CREBBP |
| Interaction | SOX2 interactions | SCYL2 PHC3 FN1 MTA3 EP400 ARID2 NANOG SEC16A ANKRD17 HELZ ACTN4 EWSR1 CHD7 EYA1 SPATS2 RUNX2 ARID1A CAPRIN1 CUX1 | 8.30e-08 | 1422 | 66 | 19 | int:SOX2 |
| Interaction | POU5F1 interactions | MTA3 EP400 NANOG ANKRD17 HELZ AFDN EWSR1 CHD7 EBF1 ARID1A PHC1 | 2.79e-06 | 584 | 66 | 11 | int:POU5F1 |
| Interaction | COMMD3-BMI1 interactions | 3.09e-06 | 31 | 66 | 4 | int:COMMD3-BMI1 | |
| Interaction | MEN1 interactions | SCYL2 MRTFB EP400 PAPOLA ARID2 NANOG ANKRD17 AFDN EWSR1 SPATS2 RUNX2 ARID1A CAPRIN1 CUX1 | 4.82e-06 | 1029 | 66 | 14 | int:MEN1 |
| Interaction | BAG2 interactions | 5.09e-06 | 622 | 66 | 11 | int:BAG2 | |
| Interaction | CTBP1 interactions | 6.71e-06 | 406 | 66 | 9 | int:CTBP1 | |
| Interaction | WWTR1 interactions | 9.15e-06 | 422 | 66 | 9 | int:WWTR1 | |
| Interaction | KDM1A interactions | CFAP100 PHC3 MRTFB MTA3 EP400 NFATC2 NANOG SEC16A ANKRD17 CRTC1 CHD7 CUX1 PHC1 | 9.45e-06 | 941 | 66 | 13 | int:KDM1A |
| Interaction | HDAC1 interactions | MRTFB FN1 MTA3 EP400 PAPOLA NFATC2 NANOG ANKRD17 CRTC1 RUNX2 ARID1A LCOR CAPRIN1 CUX1 | 1.12e-05 | 1108 | 66 | 14 | int:HDAC1 |
| Interaction | TERF2IP interactions | 1.16e-05 | 552 | 66 | 10 | int:TERF2IP | |
| Interaction | ZYX interactions | 1.17e-05 | 329 | 66 | 8 | int:ZYX | |
| Interaction | KLF6 interactions | 1.49e-05 | 95 | 66 | 5 | int:KLF6 | |
| Interaction | RBBP4 interactions | 1.61e-05 | 573 | 66 | 10 | int:RBBP4 | |
| Interaction | AR interactions | FN1 MTA3 EP400 ARID2 SEC16A ACTN4 CHD7 RUNX2 ARID1A PPID TNS1 LCOR CUX1 | 1.66e-05 | 992 | 66 | 13 | int:AR |
| Interaction | ASF1A interactions | 1.69e-05 | 249 | 66 | 7 | int:ASF1A | |
| Interaction | SERGEF interactions | 1.82e-05 | 16 | 66 | 3 | int:SERGEF | |
| Interaction | HDAC2 interactions | MTA3 EP400 NANOG ANKRD17 RCBTB2 ACTN4 EWSR1 SPATS2 ARID1A WNK1 CAPRIN1 PHC1 | 2.10e-05 | 865 | 66 | 12 | int:HDAC2 |
| Interaction | NANOG interactions | 2.58e-05 | 481 | 66 | 9 | int:NANOG | |
| Interaction | SIRT7 interactions | FN1 SUPT6H SEC16A ANKRD17 HELZ AFDN ACTN4 EWSR1 CHD7 ARID1A CAPRIN1 | 2.72e-05 | 744 | 66 | 11 | int:SIRT7 |
| Interaction | ARID1A interactions | 3.27e-05 | 276 | 66 | 7 | int:ARID1A | |
| Interaction | HNF1B interactions | 3.69e-05 | 190 | 66 | 6 | int:HNF1B | |
| Interaction | FHL2 interactions | 4.40e-05 | 396 | 66 | 8 | int:FHL2 | |
| Interaction | ETS1 interactions | 4.79e-05 | 121 | 66 | 5 | int:ETS1 | |
| Interaction | FEV interactions | 5.33e-05 | 203 | 66 | 6 | int:FEV | |
| Interaction | TSG101 interactions | 5.91e-05 | 303 | 66 | 7 | int:TSG101 | |
| Interaction | PPIAP22 interactions | 6.31e-05 | 4 | 66 | 2 | int:PPIAP22 | |
| Interaction | VEGFA interactions | 6.49e-05 | 66 | 66 | 4 | int:VEGFA | |
| Interaction | FOS interactions | 7.10e-05 | 312 | 66 | 7 | int:FOS | |
| Interaction | HDAC3 interactions | 7.24e-05 | 313 | 66 | 7 | int:HDAC3 | |
| Interaction | H2BC8 interactions | 1.04e-04 | 576 | 66 | 9 | int:H2BC8 | |
| Interaction | NUP50 interactions | 1.23e-04 | 341 | 66 | 7 | int:NUP50 | |
| Interaction | SMARCA4 interactions | 1.29e-04 | 462 | 66 | 8 | int:SMARCA4 | |
| Interaction | TFE3 interactions | 1.30e-04 | 344 | 66 | 7 | int:TFE3 | |
| Interaction | PPIA interactions | SCYL2 FN1 EP400 ARID2 HGS SEC16A EWSR1 ARID1A PPID CAPRIN1 CUX1 | 1.33e-04 | 888 | 66 | 11 | int:PPIA |
| Interaction | TFAP4 interactions | 1.45e-04 | 153 | 66 | 5 | int:TFAP4 | |
| Interaction | CLTA interactions | 1.48e-04 | 351 | 66 | 7 | int:CLTA | |
| Interaction | SOX7 interactions | 1.51e-04 | 82 | 66 | 4 | int:SOX7 | |
| Interaction | SMARCC2 interactions | 1.53e-04 | 353 | 66 | 7 | int:SMARCC2 | |
| Interaction | SALL4 interactions | 1.59e-04 | 83 | 66 | 4 | int:SALL4 | |
| Interaction | IRF4 interactions | 1.74e-04 | 85 | 66 | 4 | int:IRF4 | |
| Interaction | PHC1 interactions | 1.82e-04 | 86 | 66 | 4 | int:PHC1 | |
| Interaction | RBPJ interactions | 1.82e-04 | 254 | 66 | 6 | int:RBPJ | |
| Interaction | SOX5 interactions | 1.90e-04 | 162 | 66 | 5 | int:SOX5 | |
| Interaction | PAX6 interactions | 1.91e-04 | 366 | 66 | 7 | int:PAX6 | |
| Interaction | NUP43 interactions | 1.92e-04 | 625 | 66 | 9 | int:NUP43 | |
| Interaction | H3C3 interactions | 2.06e-04 | 495 | 66 | 8 | int:H3C3 | |
| Interaction | ESRRB interactions | 2.16e-04 | 262 | 66 | 6 | int:ESRRB | |
| Interaction | HNRNPA1 interactions | FN1 PAPOLA CENPC NFATC2 ASXL3 ARID2 SEC16A AFDN ACTN4 EWSR1 CAPRIN1 | 2.29e-04 | 945 | 66 | 11 | int:HNRNPA1 |
| Interaction | EGR2 interactions | 2.44e-04 | 171 | 66 | 5 | int:EGR2 | |
| Interaction | CBX3 interactions | 2.45e-04 | 646 | 66 | 9 | int:CBX3 | |
| Interaction | SMARCC1 interactions | 2.56e-04 | 384 | 66 | 7 | int:SMARCC1 | |
| Interaction | TLX1 interactions | 2.72e-04 | 175 | 66 | 5 | int:TLX1 | |
| Interaction | TEAD1 interactions | 2.79e-04 | 176 | 66 | 5 | int:TEAD1 | |
| Interaction | HNF4A interactions | 2.80e-04 | 275 | 66 | 6 | int:HNF4A | |
| Interaction | TIA1 interactions | 2.80e-04 | 275 | 66 | 6 | int:TIA1 | |
| Interaction | PARP1 interactions | PHC3 FN1 MTA3 EP400 CENPC NFATC2 SUPT6H NANOG PKNOX1 EWSR1 CHD7 CUX1 PHC1 | 2.93e-04 | 1316 | 66 | 13 | int:PARP1 |
| Interaction | NAA40 interactions | SCYL2 PHC3 MRTFB EP400 PAPOLA ARID2 SEC16A AAK1 ANKRD17 HELZ WNK1 | 3.08e-04 | 978 | 66 | 11 | int:NAA40 |
| Interaction | TNRC6A interactions | 3.08e-04 | 280 | 66 | 6 | int:TNRC6A | |
| Interaction | TFCP2L1 interactions | 3.13e-04 | 99 | 66 | 4 | int:TFCP2L1 | |
| Interaction | CIC interactions | 3.31e-04 | 673 | 66 | 9 | int:CIC | |
| Interaction | LHX2 interactions | 3.34e-04 | 183 | 66 | 5 | int:LHX2 | |
| Interaction | FBRS interactions | 3.50e-04 | 102 | 66 | 4 | int:FBRS | |
| Interaction | CLTB interactions | 3.51e-04 | 185 | 66 | 5 | int:CLTB | |
| Interaction | FXR1 interactions | 3.53e-04 | 679 | 66 | 9 | int:FXR1 | |
| Interaction | ACTL6A interactions | 3.65e-04 | 289 | 66 | 6 | int:ACTL6A | |
| Interaction | SUPT5H interactions | 3.69e-04 | 408 | 66 | 7 | int:SUPT5H | |
| Interaction | SMC5 interactions | PHC3 EP400 CENPC ARID2 SEC16A AFDN EWSR1 CHD7 ARID1A LCOR CUX1 | 3.72e-04 | 1000 | 66 | 11 | int:SMC5 |
| Interaction | SMAP2 interactions | 3.87e-04 | 189 | 66 | 5 | int:SMAP2 | |
| Interaction | VASP interactions | 3.99e-04 | 294 | 66 | 6 | int:VASP | |
| Interaction | GPALPP1 interactions | 4.04e-04 | 44 | 66 | 3 | int:GPALPP1 | |
| Interaction | KLF5 interactions | 4.46e-04 | 195 | 66 | 5 | int:KLF5 | |
| Interaction | NUP35 interactions | 4.64e-04 | 424 | 66 | 7 | int:NUP35 | |
| Interaction | EN1 interactions | 4.67e-04 | 110 | 66 | 4 | int:EN1 | |
| Interaction | C1S interactions | 4.67e-04 | 10 | 66 | 2 | int:C1S | |
| Interaction | YAF2 interactions | 4.68e-04 | 197 | 66 | 5 | int:YAF2 | |
| Interaction | RBBP9 interactions | 5.70e-04 | 11 | 66 | 2 | int:RBBP9 | |
| Interaction | SSBP3 interactions | 6.28e-04 | 119 | 66 | 4 | int:SSBP3 | |
| Interaction | TDRD3 interactions | 6.52e-04 | 212 | 66 | 5 | int:TDRD3 | |
| Interaction | YWHAG interactions | FN1 NFATC2 NFATC3 SEC16A AAK1 ANKRD17 HELZ CRTC1 AFDN ACTN4 EWSR1 WNK1 | 6.59e-04 | 1248 | 66 | 12 | int:YWHAG |
| Interaction | RCBTB2 interactions | 6.61e-04 | 52 | 66 | 3 | int:RCBTB2 | |
| Interaction | MEIS1 interactions | 6.61e-04 | 52 | 66 | 3 | int:MEIS1 | |
| Interaction | RUNX1 interactions | 6.66e-04 | 324 | 66 | 6 | int:RUNX1 | |
| Interaction | EYA2 interactions | 6.69e-04 | 121 | 66 | 4 | int:EYA2 | |
| Interaction | SOX21 interactions | 6.83e-04 | 12 | 66 | 2 | int:SOX21 | |
| Interaction | GTSE1 interactions | 6.95e-04 | 215 | 66 | 5 | int:GTSE1 | |
| Interaction | YWHAE interactions | FN1 PAPOLA NFATC2 AAK1 ANKRD17 CRTC1 AFDN ACTN4 EWSR1 WNK1 LCOR CAPRIN1 | 6.98e-04 | 1256 | 66 | 12 | int:YWHAE |
| Interaction | EED interactions | PHC3 FN1 MTA3 EP400 CENPC SUPT6H NANOG AFDN ACTN4 CHD7 ARID1A LCOR PHC1 | 7.15e-04 | 1445 | 66 | 13 | int:EED |
| Interaction | KLF8 interactions | 7.21e-04 | 329 | 66 | 6 | int:KLF8 | |
| Interaction | JARID2 interactions | 7.39e-04 | 54 | 66 | 3 | int:JARID2 | |
| Interaction | SCMH1 interactions | 7.39e-04 | 54 | 66 | 3 | int:SCMH1 | |
| Interaction | HPRT1 interactions | 7.55e-04 | 125 | 66 | 4 | int:HPRT1 | |
| Interaction | XRCC6 interactions | 8.27e-04 | 928 | 66 | 10 | int:XRCC6 | |
| Interaction | GATAD2A interactions | 8.36e-04 | 224 | 66 | 5 | int:GATAD2A | |
| Interaction | NFIX interactions | 8.87e-04 | 227 | 66 | 5 | int:NFIX | |
| Interaction | RFC4 interactions | 8.87e-04 | 227 | 66 | 5 | int:RFC4 | |
| Interaction | STAT5A interactions | 9.00e-04 | 131 | 66 | 4 | int:STAT5A | |
| Interaction | KLF3 interactions | 9.05e-04 | 228 | 66 | 5 | int:KLF3 | |
| GeneFamily | Nuclear factors of activated T-cells | 6.58e-05 | 5 | 47 | 2 | 665 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.52e-04 | 53 | 47 | 3 | 532 | |
| GeneFamily | AT-rich interaction domain containing | 6.80e-04 | 15 | 47 | 2 | 418 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 2.07e-03 | 26 | 47 | 2 | 526 | |
| GeneFamily | SH2 domain containing | 2.30e-03 | 101 | 47 | 3 | 741 | |
| GeneFamily | Fibronectin type III domain containing | 8.29e-03 | 160 | 47 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.44e-03 | 161 | 47 | 3 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.16e-02 | 181 | 47 | 3 | 694 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.31e-02 | 67 | 47 | 2 | 519 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 1.75e-08 | 247 | 69 | 9 | MM1081 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 1.44e-07 | 226 | 69 | 8 | M2521 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 7.34e-06 | 177 | 69 | 6 | M39245 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.47e-05 | 200 | 69 | 6 | M302 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PHC3 CD244 EP400 PAPOLA CENPC NFATC2 NFATC3 ARID2 AAK1 HELZ EVI2B RUNX2 ARID1A WNK1 | 2.85e-05 | 1492 | 69 | 14 | M40023 |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 3.40e-05 | 24 | 69 | 3 | MM627 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN | 3.40e-05 | 24 | 69 | 3 | M1437 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MTA3 ANKRD17 EWSR1 CHD7 EYA1 SPATS2 ARID1A WNK1 CAPRIN1 MEIS1 CUX1 | 6.15e-05 | 1009 | 69 | 11 | M157 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | 1.43e-04 | 433 | 69 | 7 | M2240 | |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 1.58e-04 | 193 | 69 | 5 | M3149 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 1.61e-04 | 194 | 69 | 5 | M8019 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 1.65e-04 | 195 | 69 | 5 | M9892 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 1.82e-04 | 199 | 69 | 5 | M9964 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 1.82e-04 | 199 | 69 | 5 | M6964 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN | 1.86e-04 | 200 | 69 | 5 | M6411 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN | 1.86e-04 | 200 | 69 | 5 | M2936 | |
| Coexpression | GSE17721_12H_VS_24H_LPS_BMDC_UP | 1.86e-04 | 200 | 69 | 5 | M4081 | |
| Coexpression | GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN | 1.86e-04 | 200 | 69 | 5 | M7209 | |
| Coexpression | GSE7852_TREG_VS_TCONV_DN | 1.86e-04 | 200 | 69 | 5 | M5752 | |
| Coexpression | PARK_HSC_MARKERS | 2.14e-04 | 44 | 69 | 3 | M6509 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 3.47e-06 | 388 | 67 | 9 | GSM538352_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1 | 4.92e-06 | 405 | 67 | 9 | GSM538343_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 6.84e-06 | 84 | 67 | 5 | GSM538345_100 | |
| CoexpressionAtlas | B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3 | 1.07e-05 | 337 | 67 | 8 | GSM777024_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1 | 3.34e-05 | 395 | 67 | 8 | GSM538351_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 3.59e-05 | 399 | 67 | 8 | GSM538345_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1 | 9.33e-05 | 338 | 67 | 7 | GSM538347_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | 1.02e-04 | 343 | 67 | 7 | GSM399400_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 1.40e-04 | 361 | 67 | 7 | GSM538385_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.61e-04 | 369 | 67 | 7 | GSM605891_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 1.80e-04 | 376 | 67 | 7 | GSM605894_500 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 1.81e-04 | 89 | 67 | 4 | GSM538352_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.89e-04 | 379 | 67 | 7 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.02e-04 | 383 | 67 | 7 | GSM538403_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.15e-04 | 387 | 67 | 7 | GSM538392_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_500 | 2.62e-04 | 98 | 67 | 4 | gudmap_developingKidney_e13.5_podocyte cells_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.88e-04 | 564 | 67 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, AA4.1+ CD117+ IL7R+ CD45R+ CD24- CD19- IgM-, Bone marrow, avg-1 | 3.93e-04 | 304 | 67 | 6 | GSM538354_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 4.12e-04 | 431 | 67 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 4.14e-04 | 46 | 67 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 4.34e-04 | 201 | 67 | 5 | gudmap_developingKidney_e15.5_500_k3 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-07 | 195 | 68 | 6 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-06 | 149 | 68 | 5 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-06 | 149 | 68 | 5 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.56e-06 | 166 | 68 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.66e-06 | 186 | 68 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.66e-06 | 186 | 68 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-05 | 193 | 68 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 197 | 68 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 1.45e-05 | 21 | 67 | 3 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | alcohol consumption measurement, waist-hip ratio | 3.04e-05 | 4 | 67 | 2 | EFO_0004343, EFO_0007878 | |
| Disease | influenza A severity measurement | 1.81e-04 | 9 | 67 | 2 | EFO_0007743 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.08e-04 | 713 | 67 | 8 | EFO_0005689 | |
| Disease | thiamine measurement | 2.26e-04 | 10 | 67 | 2 | EFO_0010540 | |
| Disease | gluteofemoral adipose tissue measurement | 2.36e-04 | 132 | 67 | 4 | EFO_0803317 | |
| Disease | sleep measurement | 2.57e-04 | 135 | 67 | 4 | EFO_0004870 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 2.76e-04 | 11 | 67 | 2 | EFO_0009923 | |
| Disease | colon cancer (implicated_via_orthology) | 2.76e-04 | 11 | 67 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 3.90e-04 | 13 | 67 | 2 | C0265338 | |
| Disease | waist-hip ratio | 4.25e-04 | 1226 | 67 | 10 | EFO_0004343 | |
| Disease | Adenocarcinoma Of Esophagus | 4.54e-04 | 14 | 67 | 2 | C0279628 | |
| Disease | Germ Cell Cancer | 5.23e-04 | 15 | 67 | 2 | C0740345 | |
| Disease | Germ cell tumor | 5.23e-04 | 15 | 67 | 2 | C0205851 | |
| Disease | Neoplasms, Embryonal and Mixed | 5.23e-04 | 15 | 67 | 2 | C0205852 | |
| Disease | caffeine measurement | 5.23e-04 | 15 | 67 | 2 | EFO_0021177 | |
| Disease | Embryonal Neoplasm | 5.23e-04 | 15 | 67 | 2 | C0027654 | |
| Disease | Neoplasms, Germ Cell and Embryonal | 5.23e-04 | 15 | 67 | 2 | C0027658 | |
| Disease | Cancer, Embryonal | 5.23e-04 | 15 | 67 | 2 | C0751364 | |
| Disease | Cancer, Embryonal and Mixed | 5.23e-04 | 15 | 67 | 2 | C0751365 | |
| Disease | total blood protein measurement | 5.47e-04 | 449 | 67 | 6 | EFO_0004536 | |
| Disease | anthropometric measurement | 5.88e-04 | 168 | 67 | 4 | EFO_0004302 | |
| Disease | T-Cell Lymphoma | 5.97e-04 | 16 | 67 | 2 | C0079772 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 8.47e-04 | 19 | 67 | 2 | EFO_0000220, GO_0097327 | |
| Disease | cumulative dose response to bevacizumab | 8.47e-04 | 19 | 67 | 2 | EFO_0005944 | |
| Disease | hearing impairment | 1.46e-03 | 98 | 67 | 3 | C1384666 | |
| Disease | C-reactive protein measurement | 1.57e-03 | 1206 | 67 | 9 | EFO_0004458 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 1.59e-03 | 26 | 67 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | Kallmann Syndrome | 1.59e-03 | 26 | 67 | 2 | C0162809 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.85e-03 | 28 | 67 | 2 | C0086432 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.85e-03 | 28 | 67 | 2 | DOID:3717 (is_marker_for) | |
| Disease | central nervous system cancer, glioma | 1.98e-03 | 29 | 67 | 2 | EFO_0000326, EFO_0005543 | |
| Disease | hematocrit | 2.01e-03 | 1011 | 67 | 8 | EFO_0004348 | |
| Disease | mean platelet volume | 2.13e-03 | 1020 | 67 | 8 | EFO_0004584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYNNSTQNGSPESPQ | 1131 | P55196 | |
| TETSQPQSSTGGYNQ | 146 | Q01844 | |
| GSPSYIQVTSPLSQQ | 116 | Q96L91 | |
| SGSPRTSQQNVYNPS | 676 | Q2M2I8 | |
| PYSTNSISSQSPLQQ | 511 | P39880 | |
| NYGSQPPSSSTSLAQ | 201 | P51813 | |
| SSYSVQVNVQPPNSN | 1066 | Q8IWK6 | |
| SGSNPYTTVTPQIIN | 606 | O43707 | |
| PQPVQTSSQQTSAGS | 826 | Q68CP9 | |
| TASNNNTAPTNATYP | 2016 | O75179 | |
| PSFSNTPNSGYTQSQ | 641 | Q14444 | |
| TPNSGYTQSQFSAPR | 646 | Q14444 | |
| SQTVPSPTINNSGQY | 296 | Q9P2D1 | |
| QYGDLQSTTVPQQTP | 76 | Q96MT7 | |
| PAQQPSYVIASTGQQ | 586 | Q9UBL0 | |
| TQYTSVPTPSIGNNL | 1336 | Q9C0F0 | |
| FPGQQIPSQSSKTQS | 581 | Q9HBZ2 | |
| STNYSLAPNTPINQN | 346 | Q14494 | |
| TGNKSNQSYPTPVTV | 291 | O95199 | |
| DQSNRAVSQGTPYNP | 336 | O00470 | |
| STLSQQAAYPQPQSQ | 571 | O14497 | |
| GSPFPSQQTTMYQQQ | 1351 | O14497 | |
| SPGSYPTVIQQQNAT | 856 | Q13469 | |
| PQTSQVSSYLPSNVS | 846 | Q9P2G4 | |
| QLTGYQLQPPASQSS | 551 | Q05BQ5 | |
| QPSQSSTYSQPGQSF | 121 | P14091 | |
| AEQSTSGQPYPTSDQ | 316 | Q96JN0 | |
| TSAGQPLAYNTKQPT | 96 | P34910 | |
| SPTTPSTNATYQLQE | 246 | Q99502 | |
| QSVVSQFYVSSQGQP | 681 | Q9ULH7 | |
| NSNGVTQKASAPTYP | 161 | Q9H9S0 | |
| SQQVTQTSCAPQPSY | 211 | P23490 | |
| SQTTQPVYNGETPLQ | 746 | P23471 | |
| NTTSSTPYQNIPCNG | 1806 | P42694 | |
| SPGQQIVSPSHQQYS | 476 | Q8NDX5 | |
| NPSITSSGQPLNVYS | 121 | P49335 | |
| TTQGSQQTQPPQKHY | 6 | P51003 | |
| GNLPCNQPNTYSVTS | 871 | Q8IZL2 | |
| PQTSGYTCNIPTESN | 656 | Q03188 | |
| QYRTSAGSPANQSPT | 446 | Q6UUV9 | |
| YRITTTPTNGQQGNS | 1206 | P02751 | |
| GTNNKNTPVYVSSPT | 126 | P17174 | |
| YLSSPQQGSQPSESS | 341 | Q494V2 | |
| VPSTTPQQTNYNSVT | 471 | Q9UH73 | |
| SGTLTSINYPQTYPN | 81 | Q96PD2 | |
| YTLSNSKGPVQPTAQ | 4996 | Q8NDH2 | |
| QSQSSAPTSQEPAYT | 301 | Q9BZW8 | |
| SGTNAQVTYSLLPPQ | 481 | Q9UN66 | |
| TYSKPNPNQISTSNG | 341 | Q9BTC8 | |
| QSQSGPFQTSSTPYL | 431 | Q13950 | |
| NYNSKPSSIPNTTLQ | 401 | P0C2Y1 | |
| SPYSPVQSQQIQSAI | 166 | P55347 | |
| NSNGVTQKASAPTYP | 161 | Q6NSW7 | |
| NTNGSQFFITTVPTP | 126 | Q08752 | |
| TNETQTSLNGVYQPP | 406 | Q9Y227 | |
| PSNYLSNNNQTSVTP | 256 | Q9Y371 | |
| MPVNTNQNFYSSPST | 786 | Q6P3W7 | |
| QYLQSTPAQSPAAGT | 1131 | O75339 | |
| TTPQYHQLQASTTPQ | 1631 | Q7KZ85 | |
| SRYQSAPSQAPGNTI | 486 | Q86XZ4 | |
| SQNYRGSVSQPSTPS | 581 | O15027 | |
| PQNEQSLQRSTSGYP | 26 | P0DV79 | |
| QTGTPQESLPTYTQT | 71 | Q8N7X2 | |
| GQPSPSAQRNYQSSS | 1121 | Q9HBL0 | |
| TPTAGYQNVASQAPQ | 666 | O14964 | |
| QITGQPSSQLQPITY | 901 | Q12968 | |
| NTTSPPLNQSQAQMY | 136 | P78364 | |
| QQVPTGASSSLNKYP | 101 | Q96LJ8 | |
| QQTAPPQQTVQYSLS | 746 | Q9H4A3 | |
| AVSNVYSQTNGAQPP | 571 | Q9ULH4 | |
| PGQRVTTTYNQSPAS | 81 | Q9UBF9 |